首頁 > 市場調查報告書 > 基礎設施

水處理

海水淡化和緩衝交換市場規模、佔有率和成長分析（按產品、技術、應用、最終用途和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1898388

海水淡化和緩衝交換市場規模、佔有率和成長分析（按產品、技術、應用、最終用途和地區分類）—產業預測，2026-2033年

Desalting and Buffer Exchange Market Size, Share, and Growth Analysis, By Product (Cassettes & Cartridges, Membrane Filters), By Technique (Filtration, Chromatography), By Application, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，海水淡化和緩衝交換市場規模將達到 14.7 億美元，到 2025 年將達到 16.2 億美元，到 2033 年將達到 34.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 10%。

受生物製藥研發和生產需求成長的推動，全球海水淡化和緩衝液交換市場正經歷顯著成長。蛋白質純化技術的日益普及和生物製藥的廣泛應用是推動這一趨勢的關鍵因素。層析法和過濾技術的創新也促進了市場擴張。製藥和生物技術產業是主要的終端用戶，對整體成長起著重要作用。儘管北美和歐洲憑藉其完善的研究基礎設施目前在市場應用方面處於領先地位，但亞太地區的新興經濟體展現出巨大的成長潛力。關鍵趨勢包括海水淡化技術的不斷進步，這些技術旨在解決緩衝液交換過程中的擴充性和永續性挑戰。未來發展很可能受到主要產業參與者之間策略聯盟和夥伴關係的影響。

海水淡化和緩衝劑交換市場促進因素

生物製藥（例如單株抗體和治療性蛋白質）需求的不斷成長是推動市場發展的主要動力。生物製藥產業的持續成長帶動了對高效純化方法的需求，凸顯了海水淡化和緩衝液交換製程的重要性。這些技術對於生產高品質生物製藥產品至關重要，並能滿足業界對先進純化解決方案的需求。此外，人們日益關注如何生產療效和安全性更高的生物製藥，這持續推動對這些創新純化策略的興趣，最終促進了海水淡化和緩衝液交換市場的進步和擴張。

海水淡化和緩衝劑交換市場限制

海水淡化和緩衝液交換市場面臨的一大挑戰是先進技術實施的高昂前期成本。實施和整合這些複雜系統所需的大量資金投入可能構成重大障礙，尤其對於預算有限的小規模實驗室和機構而言更是如此。這種資金障礙會限制創新解決方案的取得和應用，最終阻礙研發活動的營運效率和效益。因此，這些技術的高成本會阻礙市場的整體成長和普及，進而影響整個產業的競爭力。

海水淡化和緩衝交換市場趨勢

在海水淡化和緩衝液交換市場，自動化和高通量技術的應用已成為一個顯著趨勢。這些技術透過減少人工操作和縮短處理時間，提高了營運效率。這項變革在生物製藥領域尤其重要，因為該領域需要處理大量的樣品，快速且有效率的處理至關重要。此外，隨著對永續性的日益重視，許多公司正致力於在海水淡化和緩衝液交換技術中採用可生物分解材料和環保方法。對自動化和環境責任的雙重關注，體現了該行業對創新和永續性的承諾，並將進一步推動市場成長和發展。

Thermo Fisher Scientific（USA）
Sartorius AG（Germany）
Merck KGaA（Germany）
Danaher Corporation（USA）
Agilent Technologies（USA）
Repligen Corporation（USA）
GE HealthCare Technologies（USA）
Bio-Works Technologies（Sweden）
Norgen Biotek Corp（Canada）
Bio-Rad Laboratories（USA）
Avantor, Inc.（USA）
Pall Corporation（USA）
Waters Corporation（USA）
EMD Millipore（USA）
Tosoh Bioscience（Japan）
PerkinElmer（USA）
Shimadzu Corporation（Japan）
Lonza Group（Switzerland）

結論與建議

簡介目錄

Product Code: SQMIG30B2031

Desalting and Buffer Exchange Market size was valued at USD 1.47 Billion in 2024 and is poised to grow from USD 1.62 Billion in 2025 to USD 3.48 Billion by 2033, growing at a CAGR of 10% during the forecast period (2026-2033).

The global market for Desalting and Buffer Exchange is experiencing significant growth, fueled by the increasing demand in biopharmaceutical research and production. Rising awareness around protein purification techniques and the expanding use of biologics are pivotal factors driving this trend. Technological innovations in chromatography and filtration methods further contribute to market expansion. The pharmaceutical and biotechnology sectors serve as primary end-users, influencing overall growth. While North America and Europe currently lead in adoption due to established research infrastructures, emerging economies within the Asia-Pacific region showcase substantial growth potential. Key trends include ongoing advancements in desalting technologies that address scalability and sustainability challenges in buffer exchange processes. Future developments will likely be shaped by strategic collaborations and partnerships among key industry players.

Top-down and bottom-up approaches were used to estimate and validate the size of the Desalting and Buffer Exchange market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Desalting and Buffer Exchange Market Segments Analysis

Global Desalting and Buffer Exchange Market is segmented by Product, Technique, Application, End-Use and region. Based on Product, the market is segmented into Cassettes & Cartridges, Membrane Filters, Spin Columns, Filter Plates, Kits and Other Consumables. Based on Technique, the market is segmented into Filtration, Chromatography and Precipitation. Based on Application, the market is segmented into Bioprocess Applications, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Diagnostic Applications. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Desalting and Buffer Exchange Market

The increasing demand for biopharmaceuticals, such as monoclonal antibodies and therapeutic proteins, significantly propels the market forward. As the biopharmaceutical sector experiences continuous growth, the requirement for efficient purification methods rises, highlighting the importance of desalting and buffer exchange processes. These techniques are essential in producing high-quality biopharmaceutical products, responding to the industry's need for enhanced purification solutions. Furthermore, the emphasis on producing biologics with improved efficacy and safety contributes to the sustained interest in these innovative purification strategies, ultimately driving advancements and expansions within the desalting and buffer exchange market.

Restraints in the Desalting and Buffer Exchange Market

A major challenge facing the desalting and buffer exchange market is the high initial costs associated with adopting advanced technologies. The substantial financial investment required for acquiring and integrating such sophisticated systems can pose significant hurdles, particularly for smaller research laboratories and organizations with constrained budgets. This financial barrier can limit their ability to access and utilize these innovative solutions, ultimately impeding their operational efficiency and effectiveness in research and development activities. As a result, the high expenses tied to these technologies may hinder broader market growth and adoption, affecting the overall competitiveness within the industry.

Market Trends of the Desalting and Buffer Exchange Market

The desalting and buffer exchange market is experiencing a significant trend towards the adoption of automated and high-throughput technologies, which enhance operational efficiency by reducing manual labor and minimizing processing times. This shift is particularly vital for the biopharmaceutical sector, where rapid and effective processing is essential given the high volumes involved. Additionally, there is a growing emphasis on sustainability, with many companies focusing on biodegradable materials and greener practices in their desalting and buffer exchange technologies. This dual emphasis on automation and environmental responsibility reflects an industry's commitment to innovation and sustainability, driving further growth and development in the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Desalting and Buffer Exchange Market Size by Product & CAGR (2026-2033)

Market Overview
Cassettes & Cartridges
Membrane Filters
Spin Columns
Filter Plates
Kits
Other Consumables

Global Desalting and Buffer Exchange Market Size by Technique & CAGR (2026-2033)

Market Overview
Filtration
Chromatography
Precipitation

Global Desalting and Buffer Exchange Market Size by Application & CAGR (2026-2033)

Market Overview
Bioprocess Applications
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Applications

Global Desalting and Buffer Exchange Market Size by End-Use & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Diagnostic Laboratories

Global Desalting and Buffer Exchange Market Size & CAGR (2026-2033)

North America (Product, Technique, Application, End-Use)
- US
- Canada
Europe (Product, Technique, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technique, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technique, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technique, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Repligen Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE HealthCare Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Works Technologies (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMD Millipore (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Bioscience (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments